Diabetes drug trialed to curb alcohol cravings
NCT ID NCT06727331
Summary
This small, early-stage study is testing whether a weekly injection of tirzepatide, a medication currently used for diabetes and weight loss, can help people with alcohol use disorder. Twenty participants will receive either the real medication or a placebo for four weeks to see if it reduces their cravings for alcohol and their drinking. The main goal is to check if the drug is safe for this use and to get a first look at whether it might help control the disorder.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Faulkner Hospital
RECRUITINGJamaica Plain, Massachusetts, 02130, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Brigham and Women's Hospital
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.